Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferrandina

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Annals of Surgical Oncology|July 11, 2013
Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapyM Petrillo, G Ferrandina, A Fagotti, et al.
Gynecologic Oncology|September 1, 1993
Expression of ras p21 oncoprotein in normal and neoplastic human endometriumG Scambia, L Catozzi, P Benedetti-Panici, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicinG Scambia, R De Vincenzo, F O Ranelletti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 28, 2011
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: impact on outcome and treatment-related complicationsG Ferrandina, A Lucidi, A Paglia, et al.
British Journal of Cancer|June 1, 1994
Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptorsG Scambia, L Catozzi, P Benedetti Panici, et al.
International Journal of Cancer|October 23, 2001
Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinomaF O Ranelletti, G Almadori, B Rocca, et al.
American Journal of Obstetrics and Gynecology|January 1, 1993
Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factorG Scambia, L Catozzi, P B Panici, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursG Scambia, F O Ranelletti, P Benedetti Panici, et al.
British Journal of Cancer|January 15, 1999
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell linesC Ferlini, G Scambia, M Marone, et al.
Gynecologic Oncology|December 15, 2012
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term resultsG Ferrandina, M G Distefano, R De Vincenzo, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Annals of Surgical Oncology|July 11, 2013
Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapyM Petrillo, G Ferrandina, A Fagotti, et al.
Gynecologic Oncology|September 1, 1993
Expression of ras p21 oncoprotein in normal and neoplastic human endometriumG Scambia, L Catozzi, P Benedetti-Panici, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicinG Scambia, R De Vincenzo, F O Ranelletti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 28, 2011
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: impact on outcome and treatment-related complicationsG Ferrandina, A Lucidi, A Paglia, et al.
British Journal of Cancer|June 1, 1994
Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptorsG Scambia, L Catozzi, P Benedetti Panici, et al.
International Journal of Cancer|October 23, 2001
Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinomaF O Ranelletti, G Almadori, B Rocca, et al.
American Journal of Obstetrics and Gynecology|January 1, 1993
Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factorG Scambia, L Catozzi, P B Panici, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursG Scambia, F O Ranelletti, P Benedetti Panici, et al.
British Journal of Cancer|January 15, 1999
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell linesC Ferlini, G Scambia, M Marone, et al.
Gynecologic Oncology|December 15, 2012
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term resultsG Ferrandina, M G Distefano, R De Vincenzo, et al.
Pageof 18